• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[经皮乳房给药后4-羟基他莫昔芬的瘤内水平及代谢情况]

[Intratumoral levels and metabolism of 4-hydroxytamoxifen after percutaneous administration at the breast level].

作者信息

Kuttenn F, Mauvais-Jarvis P

出版信息

C R Acad Sci III. 1985;300(12):457-62.

PMID:3924356
Abstract

(3H)-4 hydroxytamoxifen (4O H Tam), the active metabolite of the antiestrogen tamoxifen (Tam) was dissolved in ethanol and locally percutaneously administered on 4 human breast carcinomas before surgery. 12, 24, 72 hrs. and 7 days later, (3H)-4O H Tam was recovered in cytosol and nuclear fractions of the tumor. Only traces of radioactivity were recovered in plasma. From these results it appears clearly that the percutaneous administration of 4O H Tam on the mammary gland yields a local antiestrogen effect without the systemic effects observed in case of oral administration of Tam.

摘要

抗雌激素他莫昔芬(Tam)的活性代谢产物(3H)-4-羟基他莫昔芬(4OH Tam)溶解于乙醇中,在手术前对4例人类乳腺癌进行局部经皮给药。12小时、24小时、72小时和7天后,在肿瘤的胞质溶胶和核级分中回收了(3H)-4OH Tam。血浆中仅回收了微量放射性物质。从这些结果可以清楚地看出,在乳腺上经皮给予4OH Tam会产生局部抗雌激素作用,而没有口服给予Tam时观察到的全身作用。

相似文献

1
[Intratumoral levels and metabolism of 4-hydroxytamoxifen after percutaneous administration at the breast level].[经皮乳房给药后4-羟基他莫昔芬的瘤内水平及代谢情况]
C R Acad Sci III. 1985;300(12):457-62.
2
trans-4-Hydroxytamoxifen concentration and metabolism after local percutaneous administration to human breast.人乳腺局部经皮给药后反式-4-羟基他莫昔芬的浓度与代谢
Cancer Res. 1986 Mar;46(3):1521-5.
3
Neoadjuvant percutaneous 4-hydroxytamoxifen decreases breast tumoral cell proliferation: a prospective controlled randomized study comparing three doses of 4-hydroxytamoxifen gel to oral tamoxifen.新辅助经皮4-羟基他莫昔芬可降低乳腺肿瘤细胞增殖:一项前瞻性对照随机研究,比较三种剂量的4-羟基他莫昔芬凝胶与口服他莫昔芬。
J Clin Oncol. 2005 May 1;23(13):2980-7. doi: 10.1200/JCO.2005.06.064.
4
Tamoxifen and metabolites in MCF7 cells: correlation between binding to estrogen receptor and inhibition of cell growth.他莫昔芬及其代谢物在MCF7细胞中的作用:与雌激素受体结合及抑制细胞生长之间的相关性。
Cancer Res. 1982 Jan;42(1):317-23.
5
[Cytotoxicity of tamoxifen and its principal metabolites in human breast cancer cell lines].[他莫昔芬及其主要代谢产物对人乳腺癌细胞系的细胞毒性]
Bull Cancer. 1996 Oct;83(10):808-15.
6
Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse.
Cancer Res. 1988 Feb 15;48(4):812-5.
7
Antiestrogen binding site and estrogen receptor mediate uptake and distribution of 4-hydroxytamoxifen-targeted doxorubicin-formaldehyde conjugate in breast cancer cells.抗雌激素结合位点和雌激素受体介导4-羟基他莫昔芬靶向阿霉素-甲醛缀合物在乳腺癌细胞中的摄取和分布。
J Med Chem. 2004 Dec 16;47(26):6509-18. doi: 10.1021/jm049496b.
8
Phase I study of percutaneous 4-hydroxy-tamoxifen with analyses of 4-hydroxy-tamoxifen concentrations in breast cancer and normal breast tissue.
Cancer Chemother Pharmacol. 1995;36(6):493-8. doi: 10.1007/BF00685799.
9
A ferrocenyl derivative of hydroxytamoxifen elicits an estrogen receptor-independent mechanism of action in breast cancer cell lines.羟他莫昔芬的二茂铁衍生物在乳腺癌细胞系中引起雌激素受体非依赖性作用机制。
J Inorg Biochem. 2010 May;104(5):503-11. doi: 10.1016/j.jinorgbio.2009.12.020. Epub 2010 Jan 7.
10
Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells.他莫昔芬和羟基他莫昔芬异构体在MCF-7人乳腺癌细胞中的生物活性、雌激素受体相互作用及纤溶酶原激活剂诱导活性
Cancer Res. 1984 Jan;44(1):112-9.